Hit enter to search or ESC to close
Soma CapitalSoma CapitalSoma Capital
  • Companies
  • Team
  • News
  • About
  • Jobs
Category

Shielddx

Shielddx

Shield Diagnostics announces launch of Target-NG test for antibiotic susceptibility in Neisseria gonorrhoeae

SAN JOSE, Calif., March 13, 2019 /PRNewswire/ -- Shield Diagnostics, an Andreessen Horowitz-backed clinical laboratory tackling antibiotic resistance by bringing precision medicine to infectious disease, announced the launch…
Juan
JuanJune 9, 2019
Shielddx

TL Biolabs (now Shielddx) Announces $4M in Funding Led by Andreessen Horowitz

TL Biolabs’ $15 genomic test provides farmers information on the health, productivity, and fertility of their cows — from early in the animal's life — so farmers can make…
Douglas
DouglasFebruary 23, 2017

© 2019 Soma Capital. All Rights Reserved

  • Companies
  • Team
  • News
  • About
  • Jobs
  • Contact Us
  • Investor Login